Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells

Yong Joo Park(Johns Hopkins University), Seulki Lee(Chungbuk National University)
Scientific Reports
September 8, 2020
Cited by 13


Related Papers